FOXM1 and central nervous system cancer: For this reason, FOXM1 can be considered a promising target for overcoming radiotherapy resistance in gliomas [105], as activation of the abovementioned oncogenic signaling pathways and proteins subsequently leads to the aberrant activation of this protein and radioresistance.